Dupilumab-associated sezary syndrome
Autor: | Austin Hamp, Jamie Hanson, Albert Alhatem, Robert A Schwartz |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | Indian Journal of Dermatology, Vol 68, Iss 4, Pp 459-462 (2023) |
Druh dokumentu: | article |
ISSN: | 0019-5154 1998-3611 |
DOI: | 10.4103/ijd.ijd_580_22 |
Popis: | Dupilumab is a monoclonal antibody that inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13), approved for the treatment of adults with moderate-to-severe atopic dermatitis (AD). While recent reports have described cases of new-onset mycosis fungoides (MF) following treatment with dupilumab for AD, to our knowledge only one patient has been delineated with the progression to SS. We present an additional case of a patient who was diagnosed with SS following treatment with dupilumab for adult-onset AD and asthma. We examine SS as a possible side effect of dupilumab while also discussing management and theories to explain this phenomenon. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |